Header Logo

Kristina M Deligiannidis MD

TitleAdjunct Professor
InstitutionUMass Chan Medical School
AddressZucker Hillside Hospital- Kaufman Bldg
75-59 263rd Street, Suite 103
Glen Oaks NY 11004
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine

    Collapse Biography 
    Collapse education and training
    University of Massachusetts Amherst, Amherst, MA, United StatesBSBiology/ Psychology
    University of Massachusetts Medical School, Worcester, MA, United StatesMDMedicine
    Collapse awards and honors
    1996Summer Intramural Research Training Award;Developmental Endocrinology/Genetics/Neuroendocrinology, NIH/NICHD
    1997Commonwealth Scholar; Univ. of Massachusetts at Amherst
    1998 - 2000Predoctoral Intramural Research Training Award;Developmental Endocrinology/Genetics/Neuroendocrine, NIH/NICHD
    2003Medical Student Clinical Research Electives Program:Pediatrics & Developmental Neuropsychiatry , NIH/NICHD
    2003 - 2004Charles J. Hoff Scholar; UMass Medical School
    2004T. Byram Karasu Award in Psychotherapy for Medical Students
    2007 - 2008ASCP/NIMH Clinical Trials in Psychopharmacology Award
    2008 - 2009APA/APIRE Junior Investigator Awards
    2009Paul F. Briscoli Award for Resident-Faculty Academic Collaboration; UMass Medical School
    2009Resident Educator Award; UMass Medical School
    2009Resident Elective Program in Clinical Research; Experimental Therapeutics/Pathophysiology Branch, NIH/NIMH
    2009Resident Elective Program in Clinical Research; Behavioral Endocrinology Branch, NIH/NIMH
    2009ASCP/NCDEU/NIMH New Investigator Award
    2010Worcester Foundation for Biomedical Research Grant
    2011Society for Biological Psychiatry (SOBP) Travel Scholarship Award
    2011Career Development Research Fellowship Award; UMass Medical Dept. Psychiatry
    2011Faculty Scholar Award; UMass Medical School
    2011 - 2013NIH/UMass Medical CTSA Pilot Project Program Grant, NIH/NCATS
    2012Faculty Teaching Award for Outstanding Resident Teaching; UMass Medical School Dept. Psychiatry
    2012 - 2014Career Development Institute (CDI) for Psychiatry Award (NIMH R25) Univ. Pittsburgh/Stanford Univ., NIH/NIMH
    2013 - 2018NIH/NIMH K23 Career Development Award, NIH/NIMH
    2013Early Career Achievement in Science and Health Award; UMass Medical School
    2013Best Doctors in America
    2013National Network of Depression Centers (NNDC) Annual Scientific Conference Travel Award
    2014ACNP (American College of Neuropsychopharmacology) Travel Award
    2014 - 2016NIH/NIMH Clinical Research Loan Repayment Program Award, NIH/NIMH
    2014NIH Early Career Reviewer, Center for Scientific Review, NIH/CSR
    2016SOBP George N Thompson Award for Distinguished Service, SOBP
    2017Barbara Albinder Collaborative Women in Science Award ($5,000), Feinstein Institute for Medical Research (FIMR)
    2017 - 2019NIH Extramural Clinical Research Loan Repayment Program Contract Competitive Renewal Award
    2018Innovation Award ($10,000), Feinstein Institute for Medical Research (FIMR)
    2019Elected to Associate Member, American College of Neuropsychopharmacology (ACNP)
    2019Jennifer and Bradley Marsh Educational Advancement Award ($3,000), Feinstein Institute for Medical Research (FIMR)
    2019 Northwell Health's Truly Rising Star (Innovation) Award

    Collapse Overview 
    Collapse overview
    Dr. Deligiannidis completed her undergraduate degrees in Biology and Psychology at the University of Massachusetts at Amherst. As a recipient of pre-doctoral Intramural Research Training Awards, she trained in molecular neuroendocrinology research at the National Institutes of Health (NIH). Dr. Deligiannidis completed additional research training at the NIH during medical school and residency in behavioral endocrinology and experimental therapeutics at the National Institute of Mental Health (NIMH). She received her medical degree from, and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School. After residency she completed a visiting fellowship and further training in multimodal neuroimaging at the Massachusetts General Hospital/Martinos Center for Biomedical Imaging. 
    Dr. Deligiannidis joined faculty at Zucker Hillside Hospital/Feinstein Institutes for Medical Research/Zucker School of Medicine at Hofstra/Northwell in September 2016 and is Board Certified by the American Board of Psychiatry and Neurology. Dr. Deligiannidis is the Director of Women's Behavioral Health at Zucker Hillside Hospital at Northwell Health. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle and pregnancy/postpartum periods. 
    Over the past ten years, Dr. Deligiannidis has been a leader in the field of perinatal depression and in novel therapeutics research. Her research program includes a focus in psychoneuroendocrinology, particularly neurosteroids and hormones, and neuroimaging in women's behavioral health. She has authored over 50 peer-reviewed articles plus several textbook chapters, has given over 70 oral presentations and presented over 100 research posters at scientific conferences. Dr. Deligiannidis has received federal, foundation and industry research funding, including prestigious NIH K23 and R01 grants. Her research efforts have been nationally recognized with many awards for research and for teaching of medical students and residents. Her research has been covered by major media outlets, including CNN, the Associated Press, National Public Radio, Boston Globe, Boston ABC News, Boston CBS News, CBS-New York, ABC-New York, Newsday and others.
    Dr. Deligiannidis actively contributes to national scientific committees and gives scientific presentations nationally and internationally. She is an Associate Member of the American College of Neuropsychopharmacology (ACNP), a member of the Society of Biological Psychiatry (SOBP), the American Society of Clinical Psychopharmacology (ASCP) and the Marcé Society of North America (perinatal mental health). She serves on the national ASCP Board of Directors, and the SOBP Council, as a reviewer on over 20 scientific journals and on the Advisory Board for the journal Acta Psychiatrica Scandinavica. She also serves as a member of the ACNP Committee on Education & Training and actively serves as a federal grant reviewer for the Center for Scientific Review at NIH. 
    Locally in metro NYC/Long Island, she serves on steering committees in both the Departments of Obstetrics & Gynecology and Psychiatry at Long Island Jewish Medical Center and Zucker Hillside Hospital and at the Katz Institute for Women's Health on Long Island. She additionally serves on Faculty Council at the Zucker School of Medicine at Hofstra/Northwell. She is a sought-out educator and mentor to medical students, nurse practitioner students, residents, fellows and faculty across Northwell Health and at its Schools of Medicine and Nursing. She serves on Faculty Council at the Zucker School of Medicine at Hofstra/Northwell.

    Collapse Rotation Projects

    Please contact Dr. Deligiannidis (kdeligian1@northwell.edu) to discuss research training/mentorship opportunities.

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Carlini SV, Osborne LM, Deligiannidis KM. Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression. Dialogues Clin Neurosci. 2023 12; 25(1):92-100. PMID: 37796239.
      Citations:    Fields:    Translation:Humans
    2. Deligiannidis KM, Vaughn R. Staying Up to Date With Evolving Postpartum Depression Pathophysiology and Treatment Research. J Clin Psychiatry. 2023 08 14; 84(4). PMID: 37585246.
      Citations:    Fields:    Translation:Humans
    3. Deligiannidis KM, Meltzer-Brody S, Maximos B, Peeper EQ, Freeman M, Lasser R, Bullock A, Kotecha M, Li S, Forrestal F, Rana N, Garcia M, Leclair B, Doherty J. Zuranolone for the Treatment of Postpartum Depression. Am J Psychiatry. 2023 09 01; 180(9):668-675. PMID: 37491938.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    4. Deligiannidis KM, Clayton AH. Patient-Specific Considerations, the GABA Pathway, and New Clinical Trial Data on Neuroactive Steroids in MDD and PPD. J Clin Psychiatry. 2023 03 16; 84(Suppl 1). PMID: 36928484.
      Citations: 1     Fields:    Translation:Humans
    5. Schmidt CT, Deligiannidis KM, Kittel-Schneider S, Frodl T, Spigset O, Paulzen M, Schoretsanitis G. Transfer of anticonvulsants and lithium into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2023 06 08; 124:110733. PMID: 36805301.
      Citations:    Fields:    Translation:Humans
    6. Deligiannidis KM, Citrome L, Huang MY, Acaster S, Fridman M, Bonthapally V, Lasser R, Kanes SJ. Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression. J Clin Psychiatry. 2023 01 30; 84(1). PMID: 36724109.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    7. Carlini SV, Lanza di Scalea T, McNally ST, Lester J, Deligiannidis KM. Management of Premenstrual Dysphoric Disorder: A Scoping Review. Int J Womens Health. 2022; 14:1783-1801. PMID: 36575726.
    8. Carlini SV, Weiss SJ, Mordukhaev L, Jacob S, Flynn HA, Deligiannidis KM. Clinical correlates of women endorsing premenstrual suicidal ideation: a cross-sectional study. Biopsychosoc Med. 2022 Nov 08; 16(1):23. PMID: 36348456.
    9. Epperson CN, Rubinow DR, Meltzer-Brody S, Deligiannidis KM, Riesenberg R, Krystal AD, Bankole K, Huang MY, Li H, Brown C, Kanes SJ, Lasser R. Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program. J Affect Disord. 2023 01 01; 320:353-359. PMID: 36191643.
      Citations: 8     Fields:    Translation:Humans
    10. Schoretsanitis G, Deligiannidis KM, Paulzen M, Spina E, de Leon J. Drug-drug interactions between psychotropic medications and oral contraceptives. Expert Opin Drug Metab Toxicol. 2022 Jun; 18(6):395-411. PMID: 35876180.
      Citations:    Fields:    Translation:Humans
    11. Deligiannidis KM, Robakis T, Homitsky SC, Ibroci E, King B, Jacob S, Coppola D, Raines S, Alataris K. Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder with peripartum onset: A multicenter, open-label, controlled proof-of-concept clinical trial (DELOS-1). J Affect Disord. 2022 11 01; 316:34-41. PMID: 35932937.
      Citations:    Fields:    Translation:Humans
    12. Wald J, Henningsson A, Hanze E, Hoffmann E, Li H, Colquhoun H, Deligiannidis KM. Allopregnanolone Concentrations in Breast Milk and Plasma from Healthy Volunteers Receiving Brexanolone Injection, With Population Pharmacokinetic Modeling of Potential Relative Infant Dose. Clin Pharmacokinet. 2022 09; 61(9):1307-1319. PMID: 35869362.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    13. Kaufman Y, Carlini SV, Deligiannidis KM. Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants. Ther Adv Psychopharmacol. 2022; 12:20451253211065859. PMID: 35111296.
    14. Carlini SV, Deligiannidis KM. Poor neonatal adaptation syndrome: Toward a clinical consensus to guide research and counseling. Acta Psychiatr Scand. 2022 01; 145(1):3-5. PMID: 34817073.
      Citations:    Fields:    Translation:Humans
    15. Schoretsanitis G, Carlini SV, John M, Kane JM, Deligiannidis KM. Antenatal Antidepressant Prescription Associated With Reduced Fetal Femur Length but Not Estimated Fetal Weight: A Retrospective Ultrasonographic Study. J Clin Psychopharmacol. 2021 Sep-Oct 01; 41(5):571-578. PMID: 34412105.
      Citations:    Fields:    Translation:Humans
    16. Deligiannidis KM, Meltzer-Brody S, Gunduz-Bruce H, Doherty J, Jonas J, Li S, Sankoh AJ, Silber C, Campbell AD, Werneburg B, Kanes SJ, Lasser R. Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2021 09 01; 78(9):951-959. PMID: 34190962.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    17. Weiss SJ, Flynn H, Christian L, Hantsoo L, di Scalea TL, Kornfield SL, Muzik M, Simeonova DI, Cooper BA, Strahm A, Deligiannidis KM. Symptom profiles of women at risk of mood disorders: A latent class analysis. J Affect Disord. 2021 12 01; 295:139-147. PMID: 34450523.
      Citations: 4     Fields:    Translation:Humans
    18. Schoretsanitis G, Westin AA, Stingl JC, Deligiannidis KM, Paulzen M, Spigset O. Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2021 04 20; 107:110228. PMID: 33358964.
      Citations: 6     Fields:    Translation:Humans
    19. Hare MM, Kroll-Desrosiers A, Deligiannidis KM. Peripartum depression: Does risk versus diagnostic status impact mother-infant bonding and perceived social support? Depress Anxiety. 2021 04; 38(4):390-399. PMID: 33615587.
      Citations: 4     Fields:    Translation:Humans
    20. Reinstein SA, Cosgrove J, Malekshahi T, Deligiannidis KM. Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians. J Clin Psychiatry. 2020 11 24; 81(6). PMID: 33238084.
      Citations: 2     Fields:    Translation:Humans
    21. Schoretsanitis G, Deligiannidis KM. Prenatal complications and neurodevelopmental outcomes in offspring: interactions and confounders. Acta Psychiatr Scand. 2020 10; 142(4):261-263. PMID: 32956487.
      Citations: 2     Fields:    Translation:Humans
    22. Deligiannidis KM, Kroll-Desrosiers AR, Tan Y, Dubuke ML, Shaffer SA. Longitudinal proneuroactive and neuroactive steroid profiles in medication-free women with, without and at-risk for perinatal depression: A liquid chromatography-tandem mass spectrometry analysis. Psychoneuroendocrinology. 2020 11; 121:104827. PMID: 32828068.
      Citations: 10     Fields:    Translation:Humans
    23. Hermann A, Deligiannidis KM, Bergink V, Monk C, Fitelson EM, Robakis TK, Birndorf C. Response to SARS-Covid-19-related visitor restrictions on labor and delivery wards in New York City. Arch Womens Ment Health. 2020 12; 23(6):793-794. PMID: 32296947.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    24. Reinstein SA, Deligiannidis KM. Acute Bipolar Psychosis Limited to the Course of?an Ectopic Pregnancy. Psychosomatics. 2020 Nov - Dec; 61(6):799-803. PMID: 32402409.
      Citations:    Fields:    Translation:Humans
    25. Schoretsanitis G, Spigset O, Stingl JC, Deligiannidis KM, Paulzen M, Westin AA. The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysis. Expert Opin Drug Metab Toxicol. 2020 May; 16(5):431-440. PMID: 32238008.
      Citations: 10     Fields:    Translation:Humans
    26. Schoretsanitis G, Westin AA, Deligiannidis KM, Spigset O, Paulzen M. Excretion of Antipsychotics Into the Amniotic Fluid, Umbilical Cord Blood, and Breast Milk: A Systematic Critical Review and Combined Analysis. Ther Drug Monit. 2020 04; 42(2):245-254. PMID: 31425493.
      Citations: 5     Fields:    Translation:Humans
    27. Carlini SV, Deligiannidis KM. Evidence-Based Treatment of Premenstrual Dysphoric Disorder: A Concise Review. J Clin Psychiatry. 2020 02 04; 81(2). PMID: 32023366.
      Citations: 5     Fields:    Translation:Humans
    28. Frieder A, Fersh M, Hainline R, Deligiannidis KM. Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development. CNS Drugs. 2019 03; 33(3):265-282. PMID: 30790145.
      Citations: 33     Fields:    Translation:HumansAnimals
    29. Duan C, Hare MM, Staring M, Deligiannidis KM. Examining the relationship between perinatal depression and neurodevelopment in infants and children through structural and functional neuroimaging research. Int Rev Psychiatry. 2019 05; 31(3):264-279. PMID: 30701993.
      Citations: 9     Fields:    Translation:Humans
    30. Deligiannidis KM, Fales CL, Kroll-Desrosiers AR, Shaffer SA, Villamarin V, Tan Y, Hall JE, Frederick BB, Sikoglu EM, Edden RA, Rothschild AJ, Moore CM. Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance?imaging and spectroscopy?study. Neuropsychopharmacology. 2019 02; 44(3):546-554. PMID: 30327498.
      Citations: 29     Fields:    Translation:Humans
    31. Reza N, Deligiannidis KM, Eustis EH, Battle CL. Complementary Health Practices for Treating Perinatal Depression. Obstet Gynecol Clin North Am. 2018 Sep; 45(3):441-454. PMID: 30092920.
      Citations: 7     Fields:    Translation:Humans
    32. Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR, Li H, Sankoh AJ, Clemson C, Schacterle A, Jonas J, Kanes S. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018 09 22; 392(10152):1058-1070. PMID: 30177236.
      Citations: 144     Fields:    Translation:HumansCTClinical Trials
    33. Buglione-Corbett R, Deligiannidis KM, Leung K, Zhang N, Lee M, Rosal MC, Moore Simas TA. Expression of inflammatory markers in women with perinatal depressive symptoms. Arch Womens Ment Health. 2018 12; 21(6):671-679. PMID: 29603018.
      Citations: 13     Fields:    Translation:Humans
    34. Silver M, Moore CM, Villamarin V, Jaitly N, Hall JE, Rothschild AJ, Deligiannidis KM. White matter integrity in medication-free women with peripartum depression: a tract-based spatial statistics study. Neuropsychopharmacology. 2018 06; 43(7):1573-1580. PMID: 29453442.
      Citations: 13     Fields:    Translation:Humans
    35. Tinkelman A, Hill EA, Deligiannidis KM. Management of New Onset Psychosis in the Postpartum Period. J Clin Psychiatry. 2017 Nov/Dec; 78(9):1423-1424. PMID: 29125722.
      Citations: 1     Fields:    Translation:Humans
    36. Duan C, Cosgrove J, Deligiannidis KM. Understanding Peripartum Depression Through Neuroimaging: a Review of Structural and Functional Connectivity and Molecular Imaging Research. Curr Psychiatry Rep. 2017 Aug 19; 19(10):70. PMID: 28823105.
      Citations: 19     Fields:    Translation:Humans
    37. Flynn HA, Spino C, Guille C, Deligiannidis KM, Maki P, Jahnke J, Rosenblum KL, Epperson CN, Weiss SJ. A Collaborative, Network-Based Approach to Advance Women's Depression Research in the United States: Preliminary Findings. J Womens Health (Larchmt). 2018 01; 27(1):51-57. PMID: 28727948.
      Citations: 5     Fields:    Translation:Humans
    38. Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffmann E, Rubinow D, Jonas J, Paul S, Meltzer-Brody S. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet. 2017 07 29; 390(10093):480-489. PMID: 28619476.
      Citations: 132     Fields:    Translation:HumansCTClinical Trials
    39. Putnam KT, Wilcox M, Robertson-Blackmore E, Sharkey K, Bergink V, Munk-Olsen T, Deligiannidis KM, Payne J, Altemus M, Newport J, Apter G, Devouche E, Viktorin A, Magnusson P, Penninx B, Buist A, Bilszta J, O'Hara M, Stuart S, Brock R, Roza S, Tiemeier H, Guille C, Epperson CN, Kim D, Schmidt P, Martinez P, Di Florio A, Wisner KL, Stowe Z, Jones I, Sullivan PF, Rubinow D, Wildenhaus K, Meltzer-Brody S. Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium. Lancet Psychiatry. 2017 06; 4(6):477-485. PMID: 28476427.
      Citations: 89     Fields:    Translation:HumansPHPublic Health
    40. Kroll-Desrosiers AR, Nephew BC, Babb JA, Guilarte-Walker Y, Moore Simas TA, Deligiannidis KM. Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year. Depress Anxiety. 2017 02; 34(2):137-146. PMID: 28133901.
      Citations: 25     Fields:    Translation:Humans
    41. Di Florio A, Putnam K, Altemus M, Apter G, Bergink V, Bilszta J, Brock R, Buist A, Deligiannidis KM, Devouche E, Epperson CN, Guille C, Kim D, Lichtenstein P, Magnusson PK, Martinez P, Munk-Olsen T, Newport J, Payne J, Penninx BW, O'Hara M, Robertson-Blackmore E, Roza SJ, Sharkey KM, Stuart S, Tiemeier H, Viktorin A, Schmidt PJ, Sullivan PF, Stowe ZN, Wisner KL, Jones I, Rubinow DR, Meltzer-Brody S. The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale. Psychol Med. 2017 Apr; 47(5):787-799. PMID: 27866476.
      Citations: 23     Fields:    Translation:Humans
    42. Jun-O'Connell AH, Butala A, Morales IB, Henninger N, Deligiannidis KM, Byatt N, Ionete C. The Prevalence of Bipolar Disorders and Association With Quality of Life in a Cohort of Patients With Multiple Sclerosis. J Neuropsychiatry Clin Neurosci. 2017; 29(1):45-51. PMID: 27539374.
      Citations: 7     Fields:    Translation:Humans
    43. Deligiannidis KM, Kroll-Desrosiers AR, Mo S, Nguyen HP, Svenson A, Jaitly N, Hall JE, Barton BA, Rothschild AJ, Shaffer SA. Peripartum neuroactive steroid and ?-aminobutyric acid profiles in women at-risk for postpartum depression. Psychoneuroendocrinology. 2016 08; 70:98-107. PMID: 27209438.
      Citations: 37     Fields:    Translation:Humans
    44. Weiss SJ, Muzik M, Deligiannidis KM, Ammerman RT, Guille C, Flynn HA. J Depress Anxiety. Gender differences in suicide risk factors among individuals with mood disorders. 2016; 218(5). View Publication.
    45. Deligiannidis KM, Kroll-Desrosiers AR, Svenson A, Jaitly N, Barton BA, Hall JE, Rothschild AJ. Cortisol response to the Trier Social Stress Test in pregnant women at risk for postpartum depression. Arch Womens Ment Health. 2016 10; 19(5):789-97. PMID: 26951216.
      Citations: 5     Fields:    Translation:Humans
    46. Deligiannidis KM. The physician-scientist workforce in the United States. Acta Psychiatr Scand. 2015 Oct; 132(4):317-8. PMID: 25950491.
      Citations: 3     Fields:    Translation:Humans
    47. Heterogeneity of postpartum depression: a latent class analysis. Lancet Psychiatry. 2015 Jan; 2(1):59-67. PMID: 26359613.
      Citations: 73     Fields:    Translation:HumansPHPublic Health
    48. ?stergaard SD, Fava M, Rothschild AJ, Deligiannidis KM. The implications of the National Institute of Mental Health Research Domain Criteria for researchers and clinicians. Acta Psychiatr Scand. 2014 Dec; 130(6):409-14. PMID: 25201294.
      Citations: 1     Fields:    Translation:Humans
    49. Babb JA, Deligiannidis KM, Murgatroyd CA, Nephew BC. Peripartum depression and anxiety as an integrative cross domain target for psychiatric preventative measures. Behav Brain Res. 2015 Jan 01; 276:32-44. PMID: 24709228.
      Citations: 11     Fields:    Translation:HumansAnimals
    50. Deligiannidis KM, Byatt N, Freeman MP. Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. J Clin Psychopharmacol. 2014 Apr; 34(2):244-55. PMID: 24525634.
      Citations: 38     Fields:    Translation:Humans
    51. Smith EG, Deligiannidis KM, Ulbricht CM, Landolin CS, Patel JK, Rothschild AJ. Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2013 Oct; 74(10):966-73. PMID: 24229746.
      Citations: 28     Fields:    Translation:Humans
    52. Deligiannidis KM, Rothschild AJ, Barton BA, Kroll-Desrosiers AR, Meyers BS, Flint AJ, Whyte EM, Mulsant BH. A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures. J Clin Psychiatry. 2013 Oct; 74(10):1003-9. PMID: 24229753.
      Citations: 5     Fields:    Translation:Humans
    53. Deligiannidis KM, Freeman MP. Complementary and alternative medicine therapies for perinatal depression. Best Pract Res Clin Obstet Gynaecol. 2014 Jan; 28(1):85-95. PMID: 24041861.
      Citations: 22     Fields:    Translation:HumansAnimals
    54. Deligiannidis KM, Sikoglu EM, Shaffer SA, Frederick B, Svenson AE, Kopoyan A, Kosma CA, Rothschild AJ, Moore CM. GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J Psychiatr Res. 2013 Jun; 47(6):816-28. PMID: 23499388.
      Citations: 64     Fields:    Translation:Humans
    55. Byatt N, Deligiannidis KM, Freeman MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand. 2013 Feb; 127(2):94-114. PMID: 23240634.
      Citations: 39     Fields:    Translation:Humans
    56. Deligiannidis KM, Girgis RR, Lau A, Balon R, Zisook S. Psychiatry resident/fellow-initiated and -designed multi-modal psychopharmacology curriculum for major depression. Acad Psychiatry. 2012 Sep 01; 36(5):414-8. PMID: 22983477.
      Citations: 2     Fields:    Translation:Humans
    57. Deligiannidis KM. Psychiatry Issue Briefs. Depression in women during childbearing years: causes, symptoms, challenges and treatment. 2011; 8(1). View Publication.
    58. Prabhakar D, Balon R, Deligiannidis, KM, Zisook S. . Revista de Trastornos del Ánimo. The American Society for Clinical Psychopharmacology’s Modules in Depression and Bipolar Disorder: Answering the Call for a Model Curriculum. 2011; 1(7):8-13.
    59. Moore Simas T, Byatt N, Deligiannidis KM. Alternative and Complementary Therapies. Clinical Roundup: How do you treat premenstrual syndrome in your practice?. 2011; 17(4):237.
    60. Deligiannidis KM, Freeman MP. Complementary and alternative medicine for the treatment of depressive disorders in women. Psychiatr Clin North Am. 2010 Jun; 33(2):441-63. PMID: 20385346.
      Citations: 17     Fields:    Translation:HumansAnimals
    61. Deligiannidis KM. Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium. J Clin Psychiatry. 2010 May; 71(5):649-50. PMID: 20492855.
      Citations: 6     Fields:    Translation:Humans
    62. Marsh WK, Deligiannidis KM. Current Psychiatry. Sex-related differences in antidepressant response: When to adjust treatment. 2010; 9(5):25-30.
    63. Meyers BS, Flint AJ, Rothschild AJ, Mulsant BH, Whyte EM, Peasley-Miklus C, Papademetriou E, Leon AC, Heo M. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry. 2009 Aug; 66(8):838-47. PMID: 19652123.
      Citations: 39     Fields:    Translation:Humans
    64. Falc?n J, Galarneau KM, Weller JL, Ron B, Chen G, Coon SL, Klein DC. Regulation of arylalkylamine N-acetyltransferase-2 (AANAT2, EC in the fish pineal organ: evidence for a role of proteasomal proteolysis. Endocrinology. 2001 May; 142(5):1804-13. PMID: 11316744.
      Citations: 9     Fields:    Translation:Animals
    Deligiannidis's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (238)
    Co-Authors (12)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors